Why the study?
Does bupivacaine exacerbate electrophysiological disorders and accelerate ventricular fibrillation during myocardial ischemia in a pig model?
Does bupivacaine exacerbate electrophysiological disorders and accelerate ventricular fibrillation during myocardial ischemia in a pig model?
Bupivacaine significantly shortens the time to ventricular fibrillation during acute myocardial ischemia in a pig model, suggesting caution is needed when using it in patients with ischemic heart disease.
Answers are grounded in this paper and cite their sources.
Bupivacaine hastens VF onset during ischemia in pigs; leaves open human relevance and precludes practice change.
The impairment of intraventricular conduction by bupivacaine may result in reentrant arrhythmias including ventricular fibrillation. The concentrations responsible for serious accidents are high (5.0 to 8.0 micrograms/ml), but likely to be lowered by myocardial ischemia which gives rise to similar disorders. Therefore we did an electrophysiological study of bupivacaine's effects in an ischemic area of the myocardium. Monophasic action potential (MAP) of the ventricular myocardium was recorded in 30 anesthetized, open-chest pigs. Conduction time and effective refractory period were also measured. Data were obtained during short periods (10-15 s) of pacing at 180 beats/min, but ventricular beats remained governed by the sinus node in the intervals. Ischemia was produced by occluding the left anterior descending coronary artery completely but transiently (up to 8 min), not far from its origin. Comparison was made between the effects of bupivacaine i.v. (n = 10), ischemia (n = 10) and both factors (n = 10). Two min after injection of bupivacaine 2.0 mg/kg (plasma levels 2.0-3.0 micrograms/ml), the duration of MAP was only slightly (7.5-15%) prolonged and its ischemia-induced shortening only slightly attenuated by bupivacaine. At the same time, conduction time was considerably (75-150%) lengthened and its ischemia-induced lengthening enhanced, so that ventricular fibrillation induced by coronary occlusion occurred sooner (about 100 instead of 300 s) in the presence of bupivacaine. Consequently, bupivacaine should be used only with caution in individuals whose myocardium is ischemic or liable to ischemia episodes.
No takes yet. Share an insight, caveat, or question.
Freysz et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: